Company intelligence / Profile preview

ATLASense Biomed

Hod Hasharon/Tel Aviv area, Israelatlasensebiomed.com ↗

Ownership: Private
Development stage: Commercial

Overview

Demonstrated reduction in mortality and cost savings through early detection of sepsis and respiratory failure; award-winning with Israeli Innovation Authority grant support. Early data show up to a "25% reduction in overall mortality" for sepsis screening and significant cost savings per patient per year by preventing hospitalizations through predictive alerts.

Therapeutic areas: OtherPulmonologyInfectious Diseases
Modalities: DeviceArtificial intelligence-based monitoring platformWearable technology (multi-sensor patch/smart shirt)
Industry: Physiological Monitoring

Partnerships

Prometheus (collaboration on predictive analytics for early sepsis screening supported by Israeli Innovation Authority grant)

Beyond the preview

Go deeper on ATLASense Biomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATLASense Biomed.

Explore the full profile